학술논문

Impulsivity across severe mental disorders: a cross-sectional study of immune markers and psychopharmacotherapy
Document Type
article
Source
BMC Psychiatry, Vol 23, Iss 1, Pp 1-11 (2023)
Subject
Impulsiveness
Cytokines
Interleukin-1
Tumor necrosis factor
Chemokine CCL5
Psychopharmacology
Psychiatry
RC435-571
Language
English
ISSN
1471-244X
Abstract
Abstract Background Impulsivity is a transdiagnostic feature linked to severe clinical expression and a potential target for psychopharmacological strategies. Biological underpinnings are largely unknown, but involvement of immune dysregulation has been indicated, and the effects of psychopharmacological agents vary. We investigated if impulsivity was associated with circulating immune marker levels and with a range of psychopharmacological treatment regimens in severe mental disorders. Methods Impulsivity was assessed in a sample (N = 657) of patients with schizophrenia or schizophreniform disorder (SCZ) (N = 116) or bipolar disorder (BD) (N = 159) and healthy participants (N = 382) using the Barratt Impulsiveness Scale (BIS-11) questionnaire. Plasma levels of systemic immune markers (RANTES, IL-1RA, IL-18, IL-18BP, sTNFR-1) were measured by enzyme immunoassays. Patients underwent thorough clinical assessment, including evaluation of psychotropic medication. Associations were assessed using linear regressions. Results Impulsivity was positively associated with SCZ (p